Gateway for:

Member Countries

Integrated surveillance of hepatitis in Tajikistan and Armenia

#T-2044


Enhanced epidemiologic and laboratory diagnostic capacity and applied research for the control of enteral and parenteral hepatitis and development of the Integrated Surveillance Information System in Tajikistan and Armenia

Tech Area / Field

  • MED-DIS/Disease Surveillance/Medicine

Status
3 Approved without Funding

Registration date
25.09.2012

Leading Institute
Republican Center for State Sanitary Epidemiological Control, Tajikistan, Dushanbe

Supporting institutes

  • Armenian Centers for Disease Control and Prevention, Armenia, Yerevan

Collaborators

  • University of California, USA, CA, San Diego

Project summary

Enteral and parenteral hepatitis are diseases characterized with significant spread, and thus of considerable importance for public health. The social and economic significance of hepatitis cannot be overemphasized. Enteral and parenteral hepatitis are critical for Tajikistan and Armenia. It is especially associated with the existing gaps in the system of epidemiological surveillance, laboratory diagnosis, problems in management of patients and integrated information link for these blocks. In this regard, both the scientific and practical interest is to develop a framework for the development of surveillance systems, laboratory diagnostics and treatment of enteral and parenteral hepatitis and an integrated information system for surveillance in Tajikistan and Armenia. Expected: to assess the existing surveillance state of hepatitis in the countries-participants; to enhance laboratory diagnostic of hepatitis; to enhance clinical management of hepatitis; to develop national surveillance standards for enteral and parenteral hepatitis; to design, develop and implement the Integrated Hepatitis Surveillance Information System; тo develop training curriculum and materials for continued post-graduate education of health professionals to improve hepatitis surveillance, diagnosis and treatment; to develop “National Hepatitis Prevention Programme” policy document.
In this project of 36 months duration the leading specialists from Tajikistan (state sanitary epidemiological service) and Armenia (National Institute of Health), and collaborator (Division of Gastroenterology, Department of Medicine, Liver Transplant, University of California, San Diego, USA) are intended to be involved.
The project implementation will provide for Armenia and Tajikistan the following deliverables: new scientific findings regarding epidemiological and clinical aspects of hepatitis in Tajikistan and Armenia; Institutional assessment of the existing surveillance of hepatitis, clinical management, laboratory capacity, and information flows, etc. in the countries-project participants; Developed strategy for the data integration; Developed software “Hepatitis Surveillance Information System”; Developed protocols for clinical management, laboratory diagnostics and surveillance of hepatitis; Developed training curriculum for continued post-graduate education of health professionals; Developed Developed methodology for assessment of the economic burden and impact of hepatitis; Developed “National Hepatitis Prevention and Control Programme” policy document and relevant public health messages and instructional materials aimed at the general public for containment of hepatitis infection.


Back